SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-22-003748
Filing Date
2022-05-17
Accepted
2022-05-17 17:01:08
Documents
2
Period of Report
2022-05-17
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K coeptis_8k.htm 8-K 30726
2 PRESS RELEASE coeptis_ex9901.htm EX-99.1 15523
  Complete submission text file 0001683168-22-003748.txt   47417
Mailing Address 105 BRADFORD RD, SUITE 420 WEXFORD PA 15090
Business Address 105 BRADFORD RD, SUITE 420 WEXFORD PA 15090 724-934-6467
Coeptis Therapeutics Inc. (Filer) CIK: 0001819663 (see all company filings)

IRS No.: 843998117 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56194 | Film No.: 22935532
SIC: 2834 Pharmaceutical Preparations